Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation

Clinical trial NCT00331162 · COMPLETED

Trial details

NCT number: NCT00331162
Sponsor: Wake Forest University Health Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Graft Rejection

Start date: 2005-02-01
Primary completion: 2011-11-28
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.